TRIO - Translational Research in Oncology-US, Inc. — Los Angeles, California

TRIO - Translational Research in Oncology-US, Inc. is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

TRIO - Translational Research in Oncology-US, Inc. has participated in 4 clinical trials.

Therapeutic areas: Metastatic Breast Cancer, Metastatic Pancreatic Cancer, Hormone Receptor Positive Breast Cancer.

Sponsors: Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for TRIO - Translational Research in Oncology-US, Inc.?

TRIO - Translational Research in Oncology-US, Inc. has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has TRIO - Translational Research in Oncology-US, Inc. conducted?

TRIO - Translational Research in Oncology-US, Inc. has 4 clinical trials on record. Their work covers Metastatic Breast Cancer, Metastatic Pancreatic Cancer, Hormone Receptor Positive Breast Cancer.

Is TRIO - Translational Research in Oncology-US, Inc. accredited by Crixeo Health?

TRIO - Translational Research in Oncology-US, Inc. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about TRIO - Translational Research in Oncology-US, Inc.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.